Motio HealthWear


It is estimated that 6% of the world's population suffers from Sleep Apnea. Obstructive Sleep Apnea is the most common type of apnea. Our ambition is to make self-diagnosing technologies accessible to as broad a public as possible.
90% of people suffering from Sleep Apnea are not diagnosed. Sleep Apnea generates High Blood Pressure, Heart Disease, Cerebral Attacks, Diabetes, Somnolence... Strokes increase by 60%, Depressions are multiplied by 3%, Road accidents are multiplied 5%.
$200 billions
This is the cost per year's of untreated sleep apnea in the USA. In France, public assistance for treating Sleep Apnea amounts to €1 billion. Our ambition is to conceive and develop innovative medical technologies that are affordable and accessible.
The main characteristics are the Algorithms which acting, together, enable what we call: "The Quality of Sleep" to be determined. Motio HW integrates mainly advanced optical and cutaneous technologies.


Mehdi Cheraitia

Mehdi Cheraitia

Cofounder & CEO-CTO

    Alexandre Antiphon

    Alexandre Antiphon

    Cofounder & COO

      Protected: JDG Upload

      There is no excerpt because this is a protected post.

      Read more
      Barcelona 2017: Mobile World Congress – Digital Health & Wellness Summit

      The Mobile World Congress (MWC) takes place in Barcelona from February 27th to March 2nd 2017, it is the world’s largest gathering for the mobile industry. In parallel with the MWC, The Digital Health & Wellness Summit (DHWS) takes place the 27th, an event where we find “the best innovators bringing digital technologies to improve […]

      Read more
      News Feed

      Following our participation at the CES 2017, we have had a positive impact in both the French and International press. As of today, find this new section reporting the last articles refering Neogia.

      Read more
      90 rue de Clery, 75002 Paris, France
      E-mail: Phone: (33) 640 595 068

      Please leave this field empty.